For example, CXCL17 was reported to be highly expressed in breast cancer, hepatocellular cancer, and colon cancer, where it contributed to poor prognosis, whereas in pancreatic cancer it might exert a protective role through stimulating anti-tumor immune responses [11,12,13,14,15]. This evidence concerns the gene CXCL17 and neoplasm.